Switch theme
Sign up to access all valuation multiples
TaiDoc Technology Corp is in the business of manufacturing and marketing electronic components and medical devices. It focuses on providing complete solutions covering Home care diagnostics, Professional instruments, and Telehealth systems. Its products and services include a Blood glucose monitoring system, Multiple parameters monitoring system, Irregular heartbeat detection, Vital sign monitor, Nebulizer, and others. The firm's manufacturing facilities are in Taipei and Taoyuan. It has three segments Manufacturing of Medical Devices, Precision Finishing Division, and Sales of Medical Devices. It derives the majority of its revenue from the Manufacturing of Medical Devices. Geographically, the company derives its key revenue from Europe and the rest from Americas, Middle East, and others.
1998
960
Last FY Revenue $155M
Last FY EBITDA $55.1M
$321M
Benchmark forward-looking revenue and EBITDA valuation multiples across generative AI, climate tech, semiconductors, online marketplaces, vertical SaaS and 220 more verticals.
In the most recent fiscal year, TaiDoc achieved revenue of $155M and an EBITDA of $55.1M.
TaiDoc expects next 12-month revenue of XXX and NTM EBITDA of XXX
See TaiDoc valuation multiples based on analyst estimates| LTM | NTM | Last FY | FY 2025 | FY 2026 | FY 2027 | |
|---|---|---|---|---|---|---|
| Revenue | n/a | XXX | $155M | XXX | XXX | XXX |
| Gross Profit | n/a | XXX | $68.5M | XXX | XXX | XXX |
| Gross Margin | n/a | XXX | 44% | XXX | XXX | XXX |
| EBITDA | n/a | XXX | $55.1M | XXX | XXX | XXX |
| EBITDA Margin | n/a | XXX | 36% | XXX | XXX | XXX |
| EBIT | n/a | XXX | $26.9M | XXX | XXX | XXX |
| EBIT Margin | n/a | XXX | 17% | XXX | XXX | XXX |
| Net Profit | $35.2M | XXX | $38.7M | XXX | XXX | XXX |
| Net Margin | n/a | XXX | 25% | XXX | XXX | XXX |
| Net Debt | XXX | XXX | n/a | XXX | XXX | XXX |
Financial data powered by Morningstar, Inc.
As of May 30, 2025, TaiDoc's stock price is TWD 139 (or $5).
TaiDoc has current market cap of TWD 13.3B (or $442M), and EV of TWD 9.6B (or $321M).
See TaiDoc trading valuation data| EV | Market Cap | Price 1D | Price 1M | Price 3M | Price 12M | EPS |
|---|---|---|---|---|---|---|
| $321M | $442M | XXX | XXX | XXX | XXX | $0.37 |
Sign up to access valuation multiples like growth-adjusted P/E, next 12-month EV/Revenue, EBITDA multiples by industry and many more
Start Free TrialAs of May 30, 2025, TaiDoc has market cap of $442M and EV of $321M.
TaiDoc's trades at 2.1x EV/Revenue multiple, and 5.8x EV/EBITDA.
Equity research analysts estimate TaiDoc's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX
TaiDoc has a P/E ratio of 12.6x.
See valuation multiples for TaiDoc and 12K+ public comps| LTM | NTM | Last FY | FY 2025 | FY 2026 | FY 2027 | |
|---|---|---|---|---|---|---|
| Market cap (current) | $442M | XXX | $442M | XXX | XXX | XXX |
| EV (current) | $321M | XXX | $321M | XXX | XXX | XXX |
| EV/Revenue | n/a | XXX | 2.1x | XXX | XXX | XXX |
| EV/EBITDA | n/a | XXX | 5.8x | XXX | XXX | XXX |
| EV/EBIT | n/a | XXX | 12.0x | XXX | XXX | XXX |
| EV/Gross Profit | n/a | XXX | n/a | XXX | XXX | XXX |
| P/E | 12.6x | XXX | 11.4x | XXX | XXX | XXX |
| EV/FCF | n/a | XXX | -17.9x | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Access all public comps and forward-looking valuation multiples like EV/Revenue in 2025, based on equity research analyst estimates.
Start Free TrialTaiDoc's revenue per employee in the last FY averaged $0.2M, while opex per employee averaged $43K for the same period.
TaiDoc's rule of 40 is unknown (metric relevant for SaaS companies only, counted as combined revenue growth rate and EBITDA margin).
TaiDoc's rule of X is unknown (created by Bessemer, rule of X is another metric relevant for SaaS companies only, ~1.5x stronger vs. the traditional Rule of 40, counted as revenue growth rate multiplied by 2.5 plus EBITDA margin).
See operational valuation multiples for TaiDoc and other 12K+ public comps| LTM | NTM | Last FY | FY 2025 | FY 2026 | FY 2027 | |
|---|---|---|---|---|---|---|
| Revenue Growth | n/a | XXX | n/a | XXX | XXX | XXX |
| EBITDA Margin | n/a | XXX | 36% | XXX | XXX | XXX |
| EBITDA Growth | n/a | XXX | n/a | XXX | XXX | XXX |
| Rule of 40 | n/a | XXX | n/a | XXX | XXX | XXX |
| Bessemer Rule of X | XXX | XXX | n/a | XXX | XXX | XXX |
| Revenue per Employee | XXX | XXX | $0.2M | XXX | XXX | XXX |
| Opex per Employee | XXX | XXX | $43K | XXX | XXX | XXX |
| S&M Expenses to Revenue | XXX | XXX | 11% | XXX | XXX | XXX |
| G&A Expenses to Revenue | XXX | XXX | n/a | XXX | XXX | XXX |
| R&D Expenses to Revenue | XXX | XXX | 8% | XXX | XXX | XXX |
| Opex to Revenue | XXX | XXX | 27% | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Benchmark public comps and private revenue and EBITDA valuation multiples across GRC software, cloud infrastructure, DevOps, online marketplaces and so much more!
| EV/Revenue | EV/EBITDA | |||||
|---|---|---|---|---|---|---|
| 2025E | 2026E | 2027E | 2025E | 2026E | 2027E | |
| Philips | XXX | XXX | XXX | XXX | XXX | XXX |
| Perspective Therapeutics | XXX | XXX | XXX | XXX | XXX | XXX |
| SmartVest | XXX | XXX | XXX | XXX | XXX | XXX |
| InfuSystem | XXX | XXX | XXX | XXX | XXX | XXX |
| Myomo | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc.
TaiDoc acquired XXX companies to date.
Last acquisition by TaiDoc was XXXXXXXX, XXXXX XXXXX XXXXXX . TaiDoc acquired XXXXXXXX for XXX (EV/Revenue multiple of XXX ).
See M&A valuation multiples| Acquired Company | EV | EV/Revenue | EV/EBITDA |
|---|---|---|---|
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
Sign up to see revenue and EBITDA valuation multiples for 60K+ M&A deals.
Start Free Trial| When was TaiDoc founded? | TaiDoc was founded in 1998. |
| Where is TaiDoc headquartered? | TaiDoc is headquartered in Taiwan. |
| How many employees does TaiDoc have? | As of today, TaiDoc has 960 employees. |
| Is TaiDoc publicy listed? | Yes, TaiDoc is a public company listed on TAI. |
| What is the stock symbol of TaiDoc? | TaiDoc trades under 4736 ticker. |
| When did TaiDoc go public? | TaiDoc went public in 2010. |
| Who are competitors of TaiDoc? | Similar companies to TaiDoc include e.g. Philips, Perspective Therapeutics, SmartVest, InfuSystem. |
| What is the current market cap of TaiDoc? | TaiDoc's current market cap is $442M |
| Is TaiDoc profitable? | Yes, TaiDoc is EBITDA-positive (as of the last 12 months). |
Get access to always up-to-date, precisely categorized 70K+ public and private valuation multiples, across tech and beyond.
